NO20041651L - Anvendelse av (11 beta,17 beta)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse - Google Patents

Anvendelse av (11 beta,17 beta)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse

Info

Publication number
NO20041651L
NO20041651L NO20041651A NO20041651A NO20041651L NO 20041651 L NO20041651 L NO 20041651L NO 20041651 A NO20041651 A NO 20041651A NO 20041651 A NO20041651 A NO 20041651A NO 20041651 L NO20041651 L NO 20041651L
Authority
NO
Norway
Prior art keywords
beta
benzodioxol
dien
propynyl
hydroxy
Prior art date
Application number
NO20041651A
Other languages
English (en)
Other versions
NO332978B1 (no
Inventor
Cornelis Sennef
Nernardus Wijnand Math Peeters
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20041651L publication Critical patent/NO20041651L/no
Publication of NO332978B1 publication Critical patent/NO332978B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår anvendelse av glukokortikoidreseptorantagonisten (lip,17P)-ll-(l,3-benzodioksol-5-yl)-17-hydroksy-17-(lpropynyl)-østra-4,9-dien-3-on (Org 34517) for fremstilling av et medikament for behandling av depresjon så vel som farmasøytiske preparater av Org 34517 for nevnte anvendelse.
NO20041651A 2001-10-26 2004-04-23 Anvendelse av (11ß,17ß)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse NO332978B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204072 2001-10-26
PCT/EP2002/011732 WO2003037354A1 (en) 2001-10-26 2002-10-21 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER

Publications (2)

Publication Number Publication Date
NO20041651L true NO20041651L (no) 2004-04-23
NO332978B1 NO332978B1 (no) 2013-02-11

Family

ID=8181136

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041651A NO332978B1 (no) 2001-10-26 2004-04-23 Anvendelse av (11ß,17ß)-11-(1,3-benzodioksol-5-yl)-17-hydroksy-17-(1-propynyl)-ostra-4,9-dien-3-on for behandling av alvorlig depressiv forstyrrelse

Country Status (26)

Country Link
US (1) US20040266863A1 (no)
EP (2) EP1652526B1 (no)
JP (1) JP4647909B2 (no)
KR (1) KR20050038580A (no)
CN (1) CN100531738C (no)
AT (2) ATE420649T1 (no)
AU (1) AU2002348996B2 (no)
BR (1) BR0213466A (no)
CA (1) CA2463446C (no)
CY (1) CY1110173T1 (no)
DE (2) DE60209248D1 (no)
DK (1) DK1652526T3 (no)
EC (1) ECSP045080A (no)
ES (1) ES2319563T3 (no)
HR (1) HRP20040370B1 (no)
HU (1) HUP0500070A3 (no)
IL (2) IL161248A0 (no)
IS (1) IS2702B (no)
MX (1) MXPA04003781A (no)
NO (1) NO332978B1 (no)
NZ (1) NZ532429A (no)
PL (1) PL206687B1 (no)
PT (1) PT1652526E (no)
RU (1) RU2302245C2 (no)
WO (1) WO2003037354A1 (no)
ZA (1) ZA200403088B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050080061A1 (en) * 2003-07-23 2005-04-14 Corcept Therapeutics, Inc. Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
AU2011236053B2 (en) * 2004-11-19 2014-06-26 Merck Sharpe & Dohme B.V. Drug combination comprising a selective serotonin reuptake inhibitor and a glucocorticoid receptor antagonist for the treatment of depression
CA2585317C (en) * 2004-11-19 2015-02-24 N.V. Organon Drug combination for the treatment of depression and related disorders comprising a selective serotonin reuptake inhibitor
JP2009535430A (ja) * 2006-05-02 2009-10-01 コーセプト セラピューティクス， インコーポレイテッド Ｉｌ−２を摂取している患者における抑うつを処置するためのグルココルチコイドレセプターｉｉアンタゴニストの使用
US8658128B2 (en) * 2011-02-03 2014-02-25 Pop Test Cortisol Llc System and method for diagnosis and treatment
WO2012145258A1 (en) * 2011-04-18 2012-10-26 Pop Test Cortisol Llc Hair loss treatment
US8986677B2 (en) * 2012-07-30 2015-03-24 Pop Test Cortisol Llc Therapeutic compositions and methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4814333A (en) * 1987-07-28 1989-03-21 The Trustees Of Dartmouth College Method for treatment of hypercortisolemic, depressed patients
DE4447401A1 (de) * 1994-12-23 1996-07-04 Schering Ag 14,17-C¶2¶-überbrückte Steroide
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19727772A1 (de) * 1997-06-30 1999-01-28 Forschungszentrum Juelich Gmbh Magnetflußsensor mit ringförmiger Sonde
AU747956B2 (en) * 1997-10-06 2002-05-30 Board Of Trustees Of The Leland Stanford Junior University Methods for treating psychosis associated with glucocorticoid related dysfunction
JP2004525135A (ja) * 2001-03-23 2004-08-19 コーセプト セラピューティクス， インコーポレイテッド 糖質コルチコイドレセプター特異的アンタゴニストを使用するストレス障害を処置するための方法
ATE492281T1 (de) * 2001-05-04 2011-01-15 Corcept Therapeutics Inc Verwendung von glucocorticoid-rezeptor- spezifischen antagonisten zur behandlung von delirium
ATE411013T1 (de) * 2001-08-31 2008-10-15 Corcept Therapeutics Inc Verfahren zur hemmung der verschlechterung der kognitiven leistungsfähigkeit bei erwachsenen mit down-syndrom

Also Published As

Publication number Publication date
ZA200403088B (en) 2005-01-24
HUP0500070A2 (hu) 2005-04-28
RU2004116082A (ru) 2005-05-10
IL161248A (en) 2010-12-30
EP1652526A2 (en) 2006-05-03
EP1441739B1 (en) 2006-02-15
DE60209248D1 (de) 2006-04-20
IL161248A0 (en) 2004-09-27
AU2002348996B2 (en) 2008-06-05
IS7204A (is) 2004-03-31
ECSP045080A (es) 2004-06-28
WO2003037354A1 (en) 2003-05-08
DK1652526T3 (da) 2009-05-18
KR20050038580A (ko) 2005-04-27
HRP20040370B1 (hr) 2012-09-30
JP4647909B2 (ja) 2011-03-09
NZ532429A (en) 2004-10-29
MXPA04003781A (es) 2004-07-30
CN1582153A (zh) 2005-02-16
HK1087357A1 (en) 2006-10-13
ATE420649T1 (de) 2009-01-15
ES2319563T3 (es) 2009-05-08
DE60230936D1 (de) 2009-03-05
EP1652526A3 (en) 2006-08-02
PL206687B1 (pl) 2010-09-30
PL369261A1 (en) 2005-04-18
EP1652526B1 (en) 2009-01-14
HRP20040370A2 (en) 2004-08-31
US20040266863A1 (en) 2004-12-30
HUP0500070A3 (en) 2012-09-28
JP2005521637A (ja) 2005-07-21
RU2302245C2 (ru) 2007-07-10
CY1110173T1 (el) 2015-01-14
EP1441739A1 (en) 2004-08-04
CA2463446A1 (en) 2003-05-08
CA2463446C (en) 2010-02-23
ATE317700T1 (de) 2006-03-15
PT1652526E (pt) 2009-02-06
NO332978B1 (no) 2013-02-11
CN100531738C (zh) 2009-08-26
IS2702B (is) 2010-11-15
BR0213466A (pt) 2004-11-09

Similar Documents

Publication Publication Date Title
DK1090029T3 (da) 14,15-Cyclopropansteroider fra 19-norandrostan-rækken, fremgangsmåde til deres fremstilling, og farmaceutiske præparater indeholdende disse forbindelser
TR200100063T2 (tr) Androst-5-en-3ß,17ß-diol için farmasötik kompozisyonlar ve kullanımlar
ATE493132T1 (de) Arzneimittel umfassend wenigstens ein gestagen
DE60330695D1 (de) Orale pharmazeutische zusammensetzung enthaltend 15-hydroxytestosteron und seine derivate
CY1110173T1 (el) Χρηση της (11 beta, 17beta)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one στη θεραπεια μειζωνος καταθλιπτικης διαταραχης
CY1108453T1 (el) Διαδικασια για την παρασκευη επλερενονης
PT1421099E (pt) Esteres de 17-alfa, 21-di-hidroxipregneno como agentes anti-androgenicos
HUP0303520A2 (hu) Hormonpótlás biztosítására szolgáló eljárások és készítmények
IL139861A (en) 17beta-AMINO-AND HYDROXYLAMINO -11 beta - ARYLSTEROID DERIVATIVES, METHODS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
BRPI0409617A (pt) combinação de um antagonista do receptor da aldosterona e um agente antiobesidade
WO2005077968A8 (en) 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
CA2459033A1 (en) Methods for inhibiting cognitive deterioration in adults with down's syndrome
BG103060A (bg) 19- нор- холан стероиди като неврохимични инициатори на промяната в действието на хипоталамуса причовек
AR018313A1 (es) Kit anticonceptivo que comprende medios para la administracion diaria de un agente anticonceptivo, uso de un compuesto esteroide que tiene un perfil deactividad que combina inherentemente las actividades progestagenicas y estrogenicas y un metodo anticonceptivo
ATE419855T1 (de) Therapie für hormonersatz und depression enthaltend dienogest
EE200300124A (et) 17alfa-fluoroalküülsteroidid, nende valmistamismeetod ja neid ühendeid sisaldavad farmatseutilised kompositsioonid
ATE377020T1 (de) Kristallines gamma-lacton der17beta-hydroxy-
TW200612963A (en) Polymorphs of 19-nor steroid derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees